0001601485-22-000012.txt : 20220304 0001601485-22-000012.hdr.sgml : 20220304 20220304162114 ACCESSION NUMBER: 0001601485-22-000012 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220302 FILED AS OF DATE: 20220304 DATE AS OF CHANGE: 20220304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rhodes Jennifer J CENTRAL INDEX KEY: 0001568249 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39990 FILM NUMBER: 22714336 MAIL ADDRESS: STREET 1: C/O ADAMAS PHARMACEUTICALS INC. STREET 2: 1900 POWELL ST., SUITE 750 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Angion Biomedica Corp. CENTRAL INDEX KEY: 0001601485 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113430072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 51 CHARLES LINDBERGH BOULEVARD CITY: UNIONDALE STATE: NY ZIP: 11553 BUSINESS PHONE: (415) 655-4899 MAIL ADDRESS: STREET 1: 51 CHARLES LINDBERGH BOULEVARD CITY: UNIONDALE STATE: NY ZIP: 11553 4 1 wf-form4_164642885246988.xml FORM 4 X0306 4 2022-03-02 0 0001601485 Angion Biomedica Corp. ANGN 0001568249 Rhodes Jennifer J C/O ANGION BIOMEDICA CORP. 51 CHARLES LINDBERGH BLVD. UNIONDALE NY 11553 0 1 0 0 See Remarks Stock Option (Right to Buy) 1.99 2022-03-02 4 A 0 175000 0 A 2032-03-01 Common Stock 175000.0 175000 D Stock Option (Right to Buy) 1.99 2022-03-02 4 A 0 100000 0 A 2032-03-01 Common Stock 100000.0 275000 D The total number of options vest in forty-eight (48) successive and equal monthly installments as measured from March 3, 2022 (the "Vesting Commencement Date"), such that 100% of the options will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. The total number of options vest in equal parts on July 31, 2022 and December 31, 2022, such that 100% of the options will be fully vested and exercisable on December 31, 2022. Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer and Secretary /s/ Jennifer J. Rhodes 2022-03-04